This brand name is authorized in Ireland, Japan, New Zealand, Romania.
The drug ACTAIR contains a combination of these active pharmaceutical ingredients (APIs):
1
|
Dermatophagoides pteronyssinus extract
UNII
57L1Z5378K - DERMATOPHAGOIDES PTERONYSSINUS
|
2
|
Dermatophagoides farinae extract
UNII
PR9U2YPF3Q - DERMATOPHAGOIDES FARINAE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V01AA03 | House dust | V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| JP | 医薬品医療機器総合機構 | 4490030F1024, 4490030F2020 |
| NZ | Medicines and Medical Devices Safety Authority | 17520, 17521 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W68034001, W68034002, W68035001, W68036001, W68036002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.